Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03687125
Title Tinostamustine Conditioning and Autologous Stem Cell (TITANIUM1)
Acronym TITANIUM1
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Mundipharma-EDO GmbH
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NOR | CHE

Facility Status City State Zip Country Details
University of Alabama Birmingham Alabama 35294 United States Details
University of Kansas Medical Center Kansas City Kansas City Kansas 66160 United States Details
Memorial Sloan Kettering Cancer Centre New York New York 10065 United States Details
Carolinas Healthcare System Charlotte North Carolina 28204 United States Details
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37203 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Froedtert & Medical College of Wisconsin, Cancer Center - Froedtert Hospital Milwaukee Wisconsin 53226 United States Details
Oslo Myeloma Center, Oslo University Hospital Oslo Norway Details
Universitatsspital Basel Basel Switzerland Details
Universitatsspital Bern Bern Switzerland Details
Department of Clinical Research Oncology/Hematology, Kantonsspital St. Gallen Saint Gallen Switzerland Details
University Hospital Zurich Zürich Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field